Thursday, May 10, 2018

Akili raises $55M to bring video game ADHD treatment to market - FierceBiotech


FierceBiotech

Akili raises $55M to bring video game ADHD treatment to market
FierceBiotech
Akili Interactive has raised $55 million to bring its prescription video game treatment for ADHD to market. The Temasek-led series C round comes five months after Akili posted positive data from a pivotal clinical trial of its digital medicine. The ...
Akili raises $55M as it prepares to submit prescription video game for people with ADHD for FDA approvalMedCity News
Akili Grabs $55M, Seeking FDA Approval of First Video Game TherapyXconomy
Temasek, corporate VCs buy into prescription digital med hopes in Akili's $55M Series CEndpoints News
MobiHealthNews -DEALSTREETASIA
all 11 news articles »

No comments:

Post a Comment